Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Idea to Innovation

University of Toronto

$122,750.00

Amino aldehyde reagents for industrial applications

EF 2007-08

Résumé
The so-called green, or waste-free technologies, are the holy grail of contemporary synthesis. Significant pressure to develop a new generation of processes that minimize waste is felt especially strongly in the pharmaceutical sector, known to be the worst in terms of the so-called E-factor. In 2006, we made a breakthrough in the synthesis of complex amines. A new generation of molecules termed aziridine aldehyde contain two functional groups, namely a secondary amine and an aldehyde, that remain orthogonal to each other in the course of chemical transformations. These molecules provide a seamless transition to the world of "protecting group-free" chemistry. Unleashing the synthetic potential of these molecules forms the basis of this proposal. Specifically, we have identified several priority directions where our work can have maximum impact. These areas include improved processes for production of marketed protease inhibitors and generation of novel kinase and protease inhibitors.The inventor has filed an intellecutal property (IP) disclosure with the University of Toronto and on behalf of the inventor, Innovations at U of T (IUT) has filed a US provisional patent reserving the right to file in Canada and all major international countries. The novel processes developed and novel chemical entities and synthisized will be commercialized, specifically licensed to companies in the fine chemical reagents business (Toronto Research Chemicals, Sigma Aldrich) and to biotechnology companies exploring kinase/protease inhibitors as reagents (Invitrogen).  With the support of IUT, the commercialization process has begun by direct contacts to several companies in the field.
Programme
Idea to Innovation
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
350231-2007
Name nom
Yudin, Andrei
Department département
Chemistry
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2007
Competition year année de concours
2007
Award amount
122750
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
500
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Manufacturing processes and products
Area of application fr
Procédés et produits industriels
Research subject code
3704
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Synthetic methodology
Research subject fr
Méthodologie en synthèse
Partie
1
Nb partie
1
Application title
Amino aldehyde reagents for industrial applications
Keyword
NA
Application summary
The so-called green, or waste-free technologies, are the holy grail of contemporary synthesis. Significant pressure to develop a new generation of processes that minimize waste is felt especially strongly in the pharmaceutical sector, known to be the worst in terms of the so-called E-factor. In 2006, we made a breakthrough in the synthesis of complex amines. A new generation of molecules termed aziridine aldehyde contain two functional groups, namely a secondary amine and an aldehyde, that remain orthogonal to each other in the course of chemical transformations. These molecules provide a seamless transition to the world of "protecting group-free" chemistry. Unleashing the synthetic potential of these molecules forms the basis of this proposal. Specifically, we have identified several priority directions where our work can have maximum impact. These areas include improved processes for production of marketed protease inhibitors and generation of novel kinase and protease inhibitors.The inventor has filed an intellecutal property (IP) disclosure with the University of Toronto and on behalf of the inventor, Innovations at U of T (IUT) has filed a US provisional patent reserving the right to file in Canada and all major international countries. The novel processes developed and novel chemical entities and synthisized will be commercialized, specifically licensed to companies in the fine chemical reagents business (Toronto Research Chemicals, Sigma Aldrich) and to biotechnology companies exploring kinase/protease inhibitors as reagents (Invitrogen).  With the support of IUT, the commercialization process has begun by direct contacts to several companies in the field.